Skip to main content
Skip to main menu Skip to spotlight region Skip to secondary region Skip to UGA region Skip to Tertiary region Skip to Quaternary region Skip to unit footer

Slideshow

Tags: treatment

Researchers from the University of Georgia have discovered a potential treatment for Chagas disease, marking the first medication with promise to successfully and safely target the parasitic infection in more than 50 years. Human clinical trials of the drug, an antiparasitic compound known as AN15368, will hopefully begin in the next few years. “I’m very optimistic,” said Rick Tarleton, corresponding author of the study and a UGA…
A new psychology study confirms that targeting one particular symptom of schizophrenia has a positive effect on other symptoms, offering significant promise for treating an aspect of schizophrenia that currently has no pharmaceutical options: A team led by Gregory Strauss published a study confirming that successfully treating the symptom avolition—reduced motivation—has a positive effect on other negative symptoms of schizophrenia.…
A new study at the University of Georgia describes a way to attack cancer cells that is potentially less harmful to the patient. Sodium chloride nanoparticles – more commonly known as salt – are toxic to cancer cells and offer the potential for therapies that have fewer negative side effects than current treatments. Led by Jin Xie, associate professor of chemistry, the study found that SCNPs can be used to deliver ions into cells and…
Fascinating new work from colleagues in the UGA Regenerative Bioscience Center. A research team, including faculty from the College of Agricultural and Environmental Sciences, the College of Engineering and associate professor of physics Qun Zhao: has found that a compound molecule used for drug delivery of insulin could be used to treat glioblastoma, an aggressive, usually fatal form of brain cancer. Glioblastoma, also known as…
Schizophrenia, a psychiatric disorder that affects about 1% of the population, is a leading cause of functional disability in the United States. Typically diagnosis has hinged on the display of visible “positive symptoms” such as hallucinations and delusions, but one key to earlier identification and treatment is a recognition of negative symptoms, and University of Georgia neuroscientists are developing novel technology-based tools to catch…

Support Franklin College

We appreciate your financial support. Your gift is important to us and helps support critical opportunities for students and faculty alike, including lectures, travel support, and any number of educational events that augment the classroom experience. Click here to learn more about giving.